Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer (Q33375313)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer
scientific article

    Statements

    Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer (English)
    John R Eckardt
    Joachim von Pawel
    Jean-Louis Pujol
    Elisabeth Quoix
    Alaknanda J Preston
    Graham Ross
    2086-2092

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit